The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to understand the prognostic impact of beta blockers on patients enrolled in long-term follow-up.
To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.